Drug Pipeline

Guadecitabine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04340843 Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the… Locally Advanced Unresectable Primary Central Chondrosarcoma Active, Not Recruiting
Phase 1/2
NCT02935361 Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic… Chronic Myelomonocytic Leukemia Active, Not Recruiting
Phase 1
NCT02998567 Combination Study of Guadecitabine/ASTX727 and Pembrolizumab Non Small Cell Lung Cancer Active, Not Recruiting
NCT03257761 Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile… Extrahepatic Bile Duct Adenocarcinoma, Biliary Type Active, Not Recruiting
Sponsors Running Guadecitabine Trials
University of Southern California (2) Royal Marsden NHS Foundation Trust (1) National Cancer Institute (NCI) (1)
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Pancreatic Cancer (1) Liver Cancer (1) Bladder Cancer (1) Cholangiocarcinoma (1) Sarcoma (1)
Get alerts when Guadecitabine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free